CDSA 2.0 provides microscopic fecal specimen examination for ova and parasites (O&P), the gold standard of diagnosis for many parasites.The report includes effective prescriptive and natural agents. Bacteria and mycology sensitivities are provided for pathogenic or potentially pathogenic organisms that have been cultured.Bacteria and mycology cultures demonstrate the presence of specific beneficial and pathogenic organisms.Secondary Bile Acids, including Lithocholic Acid (LCA) and Deoxycholic Acid (DCA), and the LCA/DCA ratio, assess the bacterial conversion of primary bile acids into secondary bile acids.Beta-glucuronidase is an enzyme produced by bacteria that relates to the metabolism and detoxification of certain substances.pH is influenced by macronutrient composition, bacterial populations, and transit time.N-butyrate is the primary fuel source for colonocytes. Beneficial Short–Chain Fatty Acids (SCFA), including n–Butyrate, are fermentation products produced by bacterial action on fiber and resistant starch.Metabolic indicators demonstrate specific and vital metabolic functions performed by the microbiota.Eosinophil Protein X is a marker of eosinophil-driven inflammation and allergic response.Produced in abundance at sites of inflammation, this biomarker has been proven clinically useful in differentiating between Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS). Calprotectin is a marker of neutrophil-driven inflammation.Putrefactive Short–Chain Fatty Acids (SCFAs) are markers of undigested protein reaching the colon.Pancreatic Elastase-1 is a marker of exocrine pancreatic function.The biomarkers from the CDSA 2.0 Profile are reported using the DIG framework, providing key clinical information for three main gastrointestinal functional areas: Utilizing cutting-edge technologies and biomarkers, this test offers valuable insight into digestive function, intestinal inflammation, and the intestinal microbiome. The Comprehensive Digestive Stool Analysis 2.0™ (CDSA 2.0) is an advanced stool test that provides immediate, actionable clinical information for the management of gastrointestinal health. Organic Acids (formerly Metabolic Analysis Profile)ĭescription Comprehensive Stool Analysis for Optimal Clinical Utility What is the Comprehensive Digestive Stool Analysis™ (CDSA 2.0)?.Allergix® IgG4 Food Antibodies – Bloodspot 30.Comprehensive Digestive Stool Analysis 2.0™ (CDSA 2.0).Comprehensive Digestive Stool Analysis 2.0™ without Parasitology.Comprehensive Digestive Stool Analysis/Parasitology™ (CDSA/P).Comprehensive Digestive Stool Analysis (CDSA)™.GI Effects® Comprehensive Profile – Stool.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |